¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå
Patient Engagement Solutions
»óǰÄÚµå : 1595026
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 114 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,502,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,507,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀº 2030³â±îÁö 349¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 199¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀº 2023-2030³â CAGR 8.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 349¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¼ÒÇÁÆ®¿þ¾î ÄÄÆ÷³ÍÆ®´Â CAGR 8.1%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 180¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼­ºñ½º ÄÄÆ÷³ÍÆ® ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 9.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 55¾ï ´Þ·¯, Áß±¹Àº CAGR 7.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀåÀº 2023³â¿¡ 55¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 54¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀº 7.9%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 7.8%¿Í 6.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 6.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ È¯ÀÚ Âü¿© ¼Ö·ç¼Ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Çö´ë ÇコÄɾ ȯÀÚ Âü¿© ¼Ö·ç¼ÇÀÌ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ȯÀÚ °ü¿© ¼Ö·ç¼Ç(PES)Àº ȯÀÚ°¡ Àû±ØÀûÀ¸·Î Ä¡·á¿¡ Âü¿©Çϰí, ÀÇ·áÁø°úÀÇ ¼ÒÅëÀ» °­È­Çϸç, °Ç°­ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â Åø¿Í Ç÷§ÆûÀ» Á¦°øÇÔÀ¸·Î½á Çö´ë ÀÇ·á¿¡ ÀÖÀ¸¸ç, Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÇコÄɾ ȯÀÚ Á᫐ ¸ðµ¨·Î ÀüȯµÇ°í ÀÖ´Â °¡¿îµ¥, PES´Â µðÁöÅÐ Çコ Ç÷§Æû, ȯÀÚ Æ÷ÅÐ, ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀ» ÅëÇØ ȯÀÚ¿Í ÀÇ·áÁøÀÇ Çù¾÷À» ÃËÁøÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ÀüȯÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» ÅëÇØ ȯÀÚ´Â ÀÚ½ÅÀÇ ÀÇ·á Á¤º¸¿¡ Á¢±ÙÇϰí, ¿¹¾àÇϰí, ÀÇ·áÁø°ú ¼ÒÅëÇϰí, Ä¡·á °èȹÀ» °ü¸®ÇÒ ¼ö ÀÖÀ¸¸ç, ÀÇ·á ¿©Á¤ Àü¹Ý¿¡ °ÉÃÄ Ç×»ó Á¤º¸¸¦ ¾ò°í Ä¡·á¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚµéÀÌ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇÑ ÅëÁ¦±ÇÀ» Á¡Á¡ ´õ ¸¹ÀÌ ¿ä±¸Çϰí ÀÖ´Â °¡¿îµ¥, PES´Â °³ÀÎÈ­µÇ°í Àû±ØÀûÀÎ Ä¡·á Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÏ¿© ¸¸Á·µµ¿Í Ä¡·á °èȹ ÁؼöÀ²À» ³ôÀÏ ¼ö ÀÖ½À´Ï´Ù.

ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀº ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­¿¡ ´ëÇÑ Ã¥ÀÓ°¨À» °¡Áú ¼ö ÀÖµµ·Ï ±³À°, ¾Ë¸², Áö¿ø ÅøÀ» Á¦°øÇÔÀ¸·Î½á ¸¸¼ºÁúȯ °ü¸®ºÎÅÍ ¿¹¹æÀû Ä¡·á±îÁö ´Ù¾çÇÑ ´ÏÁî¿¡ ´ëÀÀÇÕ´Ï´Ù. ¿¹¸¦ µé¾î PES´Â ȯÀÚÀÇ »óÅ¿¡ µû¶ó °³ÀÎÈ­µÈ ±³À° ÄÁÅÙÃ÷¸¦ Á¦°øÇÏ¿© Áø´Ü ¹× Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ÀÌÇØ¸¦ µµ¿ï ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ȯÀÚ°¡ ÀÇ»ç°áÁ¤¿¡ Àû±ØÀûÀ¸·Î Âü¿©ÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ÀÌÇØµµ, ¼øÀÀµµ, µ¿±âºÎ¿©¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯ °ü¸®¿¡¼­ PES´Â º¹¾à ¼øÀÀµµ ¾Ë¸², Áõ»ó ÃßÀû, °¡»ó üũÀÎ µîÀ» ÅëÇØ Áö¼ÓÀûÀÎ °ü¸®¸¦ Áö¿øÇÏ¿© ȯÀÚ°¡ º¹ÀâÇÑ ÁúȯÀ» ½±°Ô °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛÀÌ ¸¸¼ºÁúȯ¿¡ ´ëÇÑ ºÎ´ã Áõ°¡¿¡ Á÷¸éÇÑ »óȲ¿¡¼­ PES´Â ´õ ³ªÀº °Ç°­ °á°ú¸¦ ÃËÁøÇÏ°í ±Þ¼º °³ÀÔÀÇ Çʿ伺À» ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù.

¶ÇÇÑ PES´Â ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» °³¼±Çϰí, ƯÈ÷ ³óÃÌ Áö¿ªÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ªÀÇ È¯Àڵ鿡°Ô Áß¿äÇÕ´Ï´Ù. ¸¹Àº Âü¿© Ç÷§Æû¿¡ ³»ÀåµÈ ¿ø°ÝÀÇ·á ±â´ÉÀ» ÅëÇØ ȯÀÚ´Â À̵¿ÇÏÁö ¾Ê°íµµ ÀÇ·á ¼­ºñ½º¸¦ ¹ÞÀ» ¼ö ÀÖÀ¸¸ç, À庮À» ³·Ãß°í ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. °¡»ó Áø·á, ¿ø°Ý ¸ð´ÏÅ͸µ, °³º°È­µÈ Äɾî Ç÷£À» ÅëÇØ ȯÀÚµéÀº Áý¿¡¼­ ¾çÁúÀÇ Áø·á¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù¼ºÀº °Åµ¿ÀÌ ºÒÆíÇϰųª ÀÚÁÖ Áø·á¸¦ ¹Þ¾Æ¾ß Çϴ ȯÀڵ鿡°Ô ƯÈ÷ À¯¿ëÇÕ´Ï´Ù. ÀÇ·á°¡ ¸ðµç »ç¶÷À» ¼ö¿ëÇϰí Á¢±Ù¼ºÀ» ³ôÀ̱â À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥, ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀº ¿ø°Ý Áø·á¿¡ ÇʼöÀûÀÎ ÀÎÇÁ¶ó¸¦ Á¦°øÇÏ¿© ÀÇ·áÀÇ ¹üÀ§¸¦ ³ÐÈ÷°í ȯÀÚ Ä£È­ÀûÀÎ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀÌ È¯ÀÚ °ü¿© ¼Ö·ç¼ÇÀ» ¾î¶»°Ô Çâ»ó½Ã۰í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀ» ´õ¿í ÀÎÅÍ·¢Æ¼ºêÇϰí, °³ÀÎÈ­µÇ°í, Á¢±ÙÇϱ⠽±°Ô ¸¸µé¾î ´Ù¾çÇÑ ÀÇ·á ÇöÀå¿¡¼­ÀÇ À¯¿ë¼ºÀ» ³ÐÈ÷°í, ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ßÀÇ ÁÖ¿ä Çõ½Å Áß Çϳª´Â ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ ÅëÇÕÀÔ´Ï´Ù. ÀΰøÁö´ÉÀº ȯÀÚ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ¸ÂÃãÇü ÀλçÀÌÆ®, Ãßõ, ¾Ë¸²À» Á¦°øÇÔÀ¸·Î½á °³ÀÎÈ­µÈ °Ç°­ °æÇèÀ» °¡´ÉÇÏ°Ô Çϸç, AI ±â¹Ý 꺿°ú °¡»ó ºñ¼­´Â ȯÀÚÀÇ Áú¹®¿¡ ´äÇϰí, Áõ»ó ÃßÀûÀ» µ½°í, Äɾî Ç÷£À» ÅëÇØ ȯÀÚ¸¦ ¾È³»ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾È³»ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ AI ±â¹Ý ÅøÀº ÀÇ·á ÇÁ·Î¹ÙÀÌ´õÀÇ Áö¼ÓÀûÀÎ °³ÀÔÀ» ÁÙÀ̰í ȯÀÚ°¡ ÀÚÀ²ÀûÀ¸·Î °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. AI´Â °³ÀÎÈ­µÈ Áö¿ø°ú °¡À̵带 Á¦°øÇÔÀ¸·Î½á PESÀÇ ±â´ÉÀ» °­È­ÇÏ¿© º¸´Ù ½Å¼ÓÇϰí ȯÀÚ Áß½ÉÀûÀÎ Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

¸ð¹ÙÀÏ Çコ(mHealth) ¿ëµµ°ú ¿þ¾î·¯ºí ±â±â´Â ȯÀÚ¿¡°Ô ½Ç½Ã°£ °Ç°­ µ¥ÀÌÅ͸¦ Á¦°øÇϰí Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» ¿ëÀÌÇÏ°Ô ÇÔÀ¸·Î½á PES¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ÇÇÆ®´Ï½º Æ®·¡Ä¿, Ç÷¾Ð°è, Ç÷´ç ¼¾¼­¿Í °°Àº ¿þ¾î·¯ºí ±â±â´Â Áß¿äÇÑ °Ç°­ ÁöÇ¥¸¦ ¼öÁýÇÏ°í ¸ð¹ÙÀÏ °Ç°­ ¿ëµµ°ú µ¿±âÈ­ÇÏ¿© ȯÀÚ°¡ ÀÚ½ÅÀÇ °æ°ú¸¦ ¸ð´ÏÅ͸µÇϰí ÀÇ·áÁø°ú µ¥ÀÌÅ͸¦ °øÀ¯ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ Á¤º¸ È帧À» ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ½Ç½Ã°£ ÀλçÀÌÆ®À» ¹ÙÅÁÀ¸·Î Ä¡·á °èȹÀ» Àû½Ã¿¡ Á¶Á¤ÇÒ ¼ö ÀÖÀ¸¸ç, ¸¸¼ºÁúȯ °ü¸®¸¦ °³¼±Çϰí ȯÀÚ°¡ °Ç°­ ¸ñÇ¥¸¦ ´Þ¼ºÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¸ð¹ÙÀÏ Çコ ÅëÇÕÀ» ÅëÇØ PES´Â ´õ¿í ÀÎÅÍ·¢Æ¼ºêÇϰí ÀûÀÀ·ÂÀÌ ³ô¾ÆÁ® ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­ µ¥ÀÌÅÍ¿¡ °ü¿©Çϰí ÀÚ½ÅÀÇ »ýȰ½À°ü ¼±ÅÃÀÌ ¹ÌÄ¡´Â ¿µÇâÀ» ÀÌÇØÇÒ ¼ö ÀÖ°Ô µË´Ï´Ù.

¿ø°ÝÀÇ·á ¹× ¿ø°Ý ¸ð´ÏÅ͸µ ±â¼úÀº ȯÀÚ¿¡°Ô ´õ ³ôÀº À¯¿¬¼º°ú °¡»ó Áø·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» Á¦°øÇÔÀ¸·Î½á ȯÀÚ Âü¿©¸¦ ´õ¿í °­È­Çϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº Âü¿© Ç÷§ÆûÀÇ ¿ø°ÝÀÇ·á ±â´ÉÀ» ÅëÇØ °¡»ó Áø·á ¿¹¾àÀ» Çϰí, ÈÄ¼Ó Áø·á¸¦ ¹Þ°í, È­»ó ÅëÈ­³ª º¸¾È ¸Þ½Ã¡À» ÅëÇØ ÀÇ·áÁø°ú ¼ÒÅëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ ÅøÀ» ÅëÇØ ȯÀÚ´Â Áý¿¡¼­ Áõ»óÀ» °ü¸®ÇÏ°í °Ç°­ »óÅ º¯È­½Ã ¾Ë¸²À» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº Áö¼ÓÀûÀÎ ¿ø°Ý Áø·á¸¦ ÃËÁøÇÔÀ¸·Î½á ´ë¸é Áø·áÀÇ Çʿ伺À» ÁÙÀ̰í, ÀÇ·á ¼­ºñ½º¸¦ º¸´Ù Æí¸®Çϰí Ä£¼÷ÇÏ°Ô ¸¸µé¾î ÁÝ´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ µµÀÔÀÌ ÁøÇàµÊ¿¡ µû¶ó PES¿Í ¿øÈ°ÇÏ°Ô ÅëÇյǾî ȯÀÚ°¡ ½Ã°£À̳ª Àå¼ÒÀÇ À庮À» ´À³¢Áö ¾Ê°í Ä¡·á¿¡ Âü¿©ÇÒ ¼ö ÀÖ´Â ÅëÇÕÀûÀÎ °æÇèÀ» Á¦°øÇÒ °ÍÀÔ´Ï´Ù.

ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀº ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ¾î¶² ÀÌÁ¡À» Á¦°øÇϴ°¡?

ȯÀÚ °ü¿© ¼Ö·ç¼ÇÀº ȯÀÚ¿¡°Ô´Â °Ç°­ »óÅ °³¼±, Á¢±Ù¼º Çâ»ó, Ä¡·á¿¡ ´ëÇÑ Çù·ÂÀû Á¢±ÙÀ» ÃËÁøÇÏ´Â µî Å« ÀÌÁ¡À» Á¦°øÇϸç, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô´Â È¿À²¼º Çâ»ó, ȯÀÚ ¸¸Á·µµ Çâ»ó, Ä¡·á °èȹ ÁؼöÀ² Çâ»ó µî ´Ù¾çÇÑ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô´Â È¿À²¼º Çâ»ó, ȯÀÚ ¸¸Á·µµ Çâ»ó, Ä¡·á °èȹ ÁؼöÀ² Çâ»ó µîÀÇ ÀÌÁ¡À» Á¦°øÇÕ´Ï´Ù. ȯÀÚ¿¡°Ô PES´Â °Ç°­ Á¤º¸, Ä¡·á °èȹ ¹× Ä¿¹Â´ÏÄÉÀÌ¼Ç Åø¿¡ ½±°Ô Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á Æí¸®ÇÏ°í °­·ÂÇÑ °æÇèÀ» Á¦°øÇÕ´Ï´Ù. PES´Â ȯÀÚ°¡ ÀÚ½ÅÀÇ ÀÇ·á±â·ÏÀ» ¿­¶÷Çϰí, ¿¹¾àÀ» ¿¹¾àÇϰí, °æ°ú¸¦ ÃßÀûÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­À» °ü¸®Çϰí ÀÌÇØÇÑ´Ù´Â ´À³¦À» °¡Áú ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ƯÈ÷ ¸¸¼ºÁúȯÀ» ¾Î°í Àִ ȯÀÚµéÀº PES°¡ Á¦°øÇÏ´Â ¿¬¼Ó¼º°ú Àϰü¼ºÀ» ÅëÇØ Á¤±âÀûÀÎ ¾Ë¸²°ú ÇコÄɾî Áö¿øÀ» ¹ÞÀ» ¼ö ÀÖÀ¸¸ç, ÀÚ°¡ °ü¸®¿Í Ä¡·á ¼øÀÀµµ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

PES´Â ¿¹¾à ¿¹¾à, ¸®¸¶Àδõ, ÈÄ¼Ó Á¶Ä¡¿Í °°Àº ÀÏ»óÀûÀÎ ¾÷¹«¸¦ ÀÚµ¿È­ÇÏ¿© ¾÷¹« È¿À²¼ºÀ» ³ôÀ̰í, °ü¸® ºÎ´ãÀ» ÁÙ¿© ȯÀÚ¿¡°Ô ´õ ¸¹Àº ½Ã°£À» ÇÒ¾ÖÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀ» ÅëÇØ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ȯÀÚÀÇ °ü½ÉÀ» ³ôÀ̰í, ¼øÀÀµµ¸¦ À¯ÁöÇϸç, ¹«´Ü ÀÌÅ»·üÀ» ³·Ãß°í, Ä¡·á ÇÁ·ÎÅäÄÝ ÁؼöÀ²À» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. PES´Â ȯÀÚ¿¡°Ô ¸íÈ®ÇÑ Áöħ°ú ±³À° ¸®¼Ò½º¿¡ ´ëÇÑ ¾×¼¼½º¸¦ Á¦°øÇÔÀ¸·Î½á ƯÈ÷ ¸¸¼ºÁúȯ °ü¸®¿¡¼­ ÀÀ±Þ °³ÀÔ°ú ÀçÀÔ¿ø ºóµµ¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ä¡·á ´ã´çÀÚ´Â ¿ø°ÝÀ¸·Î ȯÀÚÀÇ °æ°ú¸¦ ÃßÀûÇϰí ȯÀÚÀÇ °Ç°­ ÁöÇ¥¿Í Ä¡·á °èȹ Áؼö¿¡ ´ëÇÑ ÃֽŠÁ¤º¸¸¦ ¹Þ¾Æ Àû½Ã¿¡ °³ÀÔÇÏ°í ´õ ³ªÀº Ä¡·á Á¶Á¤À» ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã½ºÅÛ ÀÔÀå¿¡¼­´Â ÀÌ·¯ÇÑ Àû±ØÀûÀÎ Á¢±Ù ¹æ½ÄÀº ȯÀÚÀÇ °á°ú¸¦ °³¼±Çϰí ÀÚ¿øÀ» º¸´Ù È¿À²ÀûÀ¸·Î »ç¿ëÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

PES´Â ȯÀÚ¿Í ÀÇ·áÁøÀÇ Çù·ÂÀûÀ̰í Åõ¸íÇÑ °ü°è¸¦ ÃËÁøÇÏ¿© Àü¹ÝÀûÀÎ Ä¡·á °æÇèÀ» Çâ»ó½Ã۱⠶§¹®¿¡ ȯÀÚ ¸¸Á·µµ¿Í Ãæ¼ºµµ°¡ ³ô¾ÆÁö´Â °ÍÀº PESÀÇ ¶Ç ´Ù¸¥ Å« ÀåÁ¡ÀÔ´Ï´Ù. ȯÀÚ´Â ÀÚ½ÅÀÇ °Ç°­ Á¤º¸¿¡ Áö¼ÓÀûÀ¸·Î Á¢±ÙÇÒ ¼ö ÀÖ°í ÀÇ·áÁø°ú Æí¸®ÇÏ°Ô ¼ÒÅëÇÒ ¼ö ÀÖÀ¸¸ç, ÀÚ½ÅÀÌ ´õ ¼ÒÁßÈ÷ ¿©°ÜÁö°í ÀÌÇØ¹Þ°í ÀÖ´Ù°í ´À³§´Ï´Ù. ¸ÂÃãÇü ±³À°, ¸ÂÃãÇü Ä¡·á °èȹ, ÁÖ¹®Çü Ä¿¹Â´ÏÄÉÀÌ¼Ç µîÀÇ ±â´ÉÀ» °®Ãá PESÀÇ °³ÀÎÈ­µÈ Ư¼ºÀº ȯÀÚ°¡ Ä¡·á¿¡ Àû±ØÀûÀ¸·Î Âü¿©Çϰí ÀÖ´Ù°í ´À³¢°ÔÇÏ¿© ½Å·Ú¿Í Âü¿©µµ¸¦ ³ôÀÔ´Ï´Ù. ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ °æ¿ì, ¸¸Á·ÇÑ È¯ÀÚ´Â Ãæ¼ºµµ¸¦ À¯ÁöÇÏ°í º´¿øÀ» ÃßõÇÒ °¡´É¼ºÀÌ ³ô¾ÆÁ® Àå±âÀûÀΠȯÀÚ À¯Áö¿Í ÁÁÀº ÆòÆÇÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀåÁ¡Àº ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÀÓ»óÀû Ãø¸é°ú ¿î¿µ Ãø¸éÀ» ¸ðµÎ °³¼±ÇÏ¿© º¸´Ù ÃÑüÀûÀ̰í ȯÀÚ Áß½ÉÀûÀÎ ÀÇ·á ¼­ºñ½º Á¢±Ù ¹æ½ÄÀ» Áö¿øÇÕ´Ï´Ù.

ȯÀÚ °ü¿© ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

ȯÀÚ °ü¿© ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀº ÀÇ·á ¼ÒºñÀÚÁÖÀÇ Áõ°¡, µðÁöÅÐ Çコ ±â¼ú ¹ßÀü, ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, ȯÀÚ Áß½É Ä¡·á¿¡ ÃÊÁ¡À» ¸ÂÃá ±ÔÁ¦ ¿ä°Ç µî¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÇコÄɾ ¼ÒºñÀÚ Áß½ÉÀ¸·Î º¯È­ÇÔ¿¡ µû¶ó ȯÀÚµéÀº °Ç°­ Á¤º¸¿¡ ´ëÇÑ Á¢±Ù°ú ¸ÂÃã Ä¡·á Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÏ´Â Æí¸®ÇÑ µðÁöÅÐ ÅøÀ» ¿øÇϰí ÀÖÀ¸¸ç, PES´Â ȯÀÚ°¡ ÀÚ½ÅÀÇ °Ç°­ »óŸ¦ ½º½º·Î °ü¸®ÇÒ ¼ö ÀÖ´Â »ç¿ëÇϱ⠽¬¿î Ç÷§ÆûÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¼ö¿ä¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÇöÀç ´Ù¸¥ ºÐ¾ß¿¡¼­ °æÇèÇÏ´Â °Í°ú µ¿ÀÏÇÑ ¼öÁØÀÇ ¼­ºñ½º¿Í ÆíÀǼºÀ» ÀÇ·á ¼­ºñ½º¿¡µµ ¿ä±¸Çϰí ÀÖÀ¸¸ç, PES´Â Á¢±Ù¼ºÀÌ ¶Ù¾î³ª°í ȯÀÚ Áß½ÉÀÇ °æÇèÀ» Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ±â´ë¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù. ÇコÄɾîÀÇ ¼ÒºñÀÚÁÖÀǰ¡ È®»êµÊ¿¡ µû¶ó È¿°úÀûÀÌ°í Æí¸®ÇÑ È¯ÀÚ °ü¿© ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

AI, ¿ø°ÝÀÇ·á, ¸ð¹ÙÀÏ Çコ ¿ëµµ°ú °°Àº ±â¼ú ¹ßÀüÀº Á¢±Ù¼º, °³ÀÎÈ­, ½Ç½Ã°£ µ¥ÀÌÅÍ °øÀ¯¸¦ °­È­ÇÔÀ¸·Î½á ȯÀÚ °ü¿© ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖÀ¸¸ç, AI ±â¹Ý ÅøÀº ȯÀÚ °³°³ÀÎÀÇ Çʿ信 µû¶ó ¸ÂÃãÇü ¾È³», ¾Ë¸², °Ç°­ ÀλçÀÌÆ®À» Á¦°øÇÔÀ¸·Î½á PES¸¦ º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î ¸¸µé¾îÁÝ´Ï´Ù. ¸ÂÃãÇü ¾È³», ¾Ë¸², °Ç°­ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© PES¸¦ º¸´Ù È¿°úÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀ¸·Î ¸¸µé¾î ÁÝ´Ï´Ù. ¿ø°ÝÀÇ·áÀÇ È®»êÀº ¿ø°Ý Áø·á¿Í ÈÄ¼Ó Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϰí, ´Ù¾çÇÑ Àå¼Ò¿¡ Àִ ȯÀڵ鿡°Ô ÀÇ·á ¼­ºñ½º¸¦ ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé¾î PESÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ °Ç°­ ¿ëµµ°ú ¿þ¾î·¯ºíÀº ½Ç½Ã°£ °Ç°­ ¸ð´ÏÅ͸µÀ» Á¦°øÇϰí PES¿Í ÅëÇÕÇÏ¿© º¸´Ù ÀÎÅÍ·¢Æ¼ºêÇÏ°í °³ÀÎÈ­µÈ °æÇèÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº PES¸¦ º¸´Ù ¹ü¿ëÀûÀ̰í È®Àå °¡´ÉÇÏ¸ç ¸Å·ÂÀûÀ¸·Î ¸¸µé¾î ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ¿Í ȯÀÚ ¸ðµÎ¿¡°Ô ´õ ³ôÀº º¸±Þ·üÀ» °¡Á®´Ù ÁÙ °ÍÀÔ´Ï´Ù.

´ç´¢º´, ½ÉÇ÷°ü Áúȯ, È£Èí±â Áúȯ°ú °°Àº ¸¸¼ºÁúȯ Áõ°¡·Î ÀÎÇØ È¿°úÀûÀÎ Áúº´ °ü¸®¸¦ Áö¿øÇϱâ À§ÇÑ Áö¼ÓÀûÀΠȯÀÚ Âü¿©ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¸¸¼ºÁúȯÀ» °ü¸®Çϱâ À§Çؼ­´Â ÀϰüµÈ ȯÀÚ ¸ð´ÏÅ͸µ, ±³À°, Ä¡·á °èȹÀÇ Áؼö µîÀÌ ÇÊ¿äÇѵ¥, PES´Â ÀÌ ¸ðµç °ÍÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ, º¹¾à ¾Ë¸², °¡»ó üũÀÎ µîÀÇ ±â´ÉÀ» °®Ãá PES´Â Àå±âÀûÀÎ °Ç°­ »óŸ¦ °¡Áø ȯÀÚ¸¦ Áö¿øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» Çϸç, ȯÀÚÀÇ Âü¿©¿Í Ä¡·á °èȹ Áؼö¸¦ µ½½À´Ï´Ù. Àü ¼¼°è¿¡¼­ ¸¸¼ºÁúȯÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ´Â ȯÀÚÀÇ ¼øÀÀµµ¸¦ ³ôÀÌ°í º´¿ø ÀçÀÔ¿øÀ» ÁÙÀÌ¸ç ±Ã±ØÀûÀ¸·Î ¸¸¼ºÁúȯ °ü¸®¿Í °ü·ÃµÈ ºñ¿ëÀ» Àý°¨Çϱâ À§ÇØ PES¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ È¯ÀÚ Âü¿©¿Í Ä¡·áÀÇ ÁúÀ» Çâ»ó½Ã۱â À§ÇÑ Áö¿øÀûÀÎ ±ÔÁ¦ ¿ä°Ç°ú Àμ¾Æ¼ºêµµ PES ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎ ÀÇ·á ÇÁ·Î±×·¥ ¹× ±ÔÁ¦±â°üÀº ȯÀÚ Á᫐ ÀǷḦ °­Á¶Çϰí ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚÀÇ °Ç°­ Âü¿©¸¦ ³ôÀÌ´Â ¼Ö·ç¼ÇÀ» äÅÃÇϵµ·Ï Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ȯÀÚÀÇ ÀÇ·á ±â·Ï¿¡ ´ëÇÑ Á¢±ÙÀ» Àǹ«È­ÇÏ´Â ¹Ì±¹ 21¼¼±â °æÈ­¹ý(21st Century Cures Act)°ú °°Àº ±ÔÁ¦´Â Åõ¸í¼º°ú ȯÀÚ ±ÇÇÑ ºÎ¿©¸¦ Çâ»ó½ÃŰ´Â PESÀÇ µµÀÔÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °¡Ä¡ ±â¹Ý ÀÇ·á ±¸»óÀº ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô ȯÀÚ Âü¿©¿Í °Ç°­ °á°ú¸¦ ¿ì¼±½ÃÇÏ´Â Àμ¾Æ¼ºê¸¦ Á¦°øÇÏ¿© PESÀÇ »ç¿ëÀ» ´õ¿í ÃËÁøÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦ ¿äÀÎÀº PESÀÇ ¸ñÇ¥¿Í ÀÏÄ¡Çϸç, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Ç¥ÁØÀ» ÁؼöÇϰí ÀÇ·áÀÇ ÁúÀ» Çâ»ó½ÃŰ·Á´Â ³ë·Â°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ÀÇ·á ¼ÒºñÀÚ ÀÎ½Ä Áõ°¡, ±â¼ú ¹ßÀü, ¸¸¼ºÁúȯ °ü¸®ÀÇ Çʿ伺, ±ÔÁ¦ Á¤Ã¥ÀÇ Áö¿ø µî ¿©·¯ ¿äÀÎÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ȯÀÚ °ü¿© ¼Ö·ç¼Ç ½ÃÀåÀÌ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. PES´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ º¸´Ù Á¢±Ù¼ºÀÌ ³ô°í, °³ÀÎÈ­µÇ°í, È¿À²ÀûÀÎ Ä¡·á¸¦ Á¦°øÇϱâ À§ÇØ ³ë·ÂÇÏ´Â °¡¿îµ¥ ȯÀÚ Á᫐ ÀÇ·áÀÇ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖÀ¸¸ç, ´õ ³ªÀº Ä¡·á °á°ú¿Í ´õ ¿­¼ºÀûÀΠȯÀÚ Áý´ÜÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

ÄÄÆ÷³ÍÆ®(¼ÒÇÁÆ®¿þ¾î, ¼­ºñ½º, Çϵå¿þ¾î);Ä¡·á ºÐ¾ß(¸¸¼ºÁúȯ, ¿©¼º °Ç°­, ÇÇÆ®´Ï½º, ±âŸ Ä¡·á ºÐ¾ß);¾ÖÇø®ÄÉÀ̼Ç(ÇコÄɾî, ÀçÅà ÇコÄɾî, »çȸ¡¤Çൿ °ü¸®, À繫 ÇコÄɾî)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 83»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Patient Engagement Solutions Market to Reach US$34.9 Billion by 2030

The global market for Patient Engagement Solutions estimated at US$19.9 Billion in the year 2023, is expected to reach US$34.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Software Component, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$18.0 Billion by the end of the analysis period. Growth in the Services Component segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 7.9% CAGR

The Patient Engagement Solutions market in the U.S. is estimated at US$5.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 6.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.9% CAGR.

Global Patient Engagement Solutions Market - Key Trends & Drivers Summarized

Why Are Patient Engagement Solutions Essential in Modern Healthcare?

Patient Engagement Solutions (PES) have become critical in modern healthcare, providing tools and platforms that empower patients to take an active role in their care, enhance communication with providers, and improve health outcomes. As healthcare transitions toward a patient-centered model, PES supports this shift by fostering collaboration between patients and providers through digital health platforms, patient portals, and mobile applications. These solutions allow patients to access their medical information, schedule appointments, communicate with their care teams, and manage treatment plans, ensuring that they stay informed and engaged throughout their healthcare journey. With patients increasingly seeking more control over their health, PES enables a personalized and proactive approach to care, enhancing satisfaction and adherence to treatment plans.

Patient Engagement Solutions address a variety of needs, from chronic disease management to preventive care, by providing education, reminders, and support tools that encourage patients to take responsibility for their health. For example, PES can deliver personalized educational content based on a patient’s condition, helping them understand their diagnosis and treatment options. By enabling patients to actively participate in decision-making, these solutions enhance understanding, adherence, and motivation. In chronic disease management, PES supports ongoing care through reminders for medication adherence, symptom tracking, and virtual check-ins, making it easier for patients to manage complex conditions. As healthcare systems face the rising burden of chronic diseases, PES plays a crucial role in promoting better health outcomes and reducing the need for acute interventions.

Moreover, PES improves access to healthcare, particularly for patients in rural or underserved areas. Telehealth capabilities embedded in many engagement platforms allow patients to access care without the need to travel, reducing barriers and enhancing the accessibility of healthcare services. Through virtual consultations, remote monitoring, and personalized care plans, patients can receive high-quality care from the convenience of their homes. This accessibility is especially valuable for patients with limited mobility or those who need frequent check-ins. As healthcare strives to be inclusive and accessible to all, patient engagement solutions provide an essential infrastructure for remote care, extending healthcare’s reach and making it more patient-friendly.

How Are Technological Advancements Enhancing Patient Engagement Solutions?

Technological advancements are significantly enhancing Patient Engagement Solutions by making them more interactive, personalized, and accessible, expanding their utility in various healthcare settings. One major innovation in this field is the integration of Artificial Intelligence (AI) and machine learning, which enable personalized health experiences by analyzing patient data to offer tailored insights, recommendations, and reminders. AI-powered chatbots and virtual assistants can answer patient questions, assist in symptom tracking, and guide patients through their care plans. These AI-driven tools reduce the need for constant provider intervention and empower patients to manage their health autonomously. By delivering personalized support and guidance, AI enhances the functionality of PES, enabling a more responsive and patient-centered approach to care.

Mobile health (mHealth) applications and wearable devices are revolutionizing PES by providing patients with real-time health data and facilitating continuous monitoring. Wearables such as fitness trackers, blood pressure monitors, and glucose sensors collect vital health metrics and sync them with mobile health applications, allowing patients to monitor their progress and share data with providers. This continuous flow of information enables healthcare providers to make timely adjustments to treatment plans based on real-time insights, improving the management of chronic conditions and helping patients stay on track with their health goals. With mobile health integration, PES becomes more interactive and adaptive, allowing patients to engage with their health data and understand the impact of their lifestyle choices.

Telehealth and remote monitoring technologies have further strengthened patient engagement by providing patients with greater flexibility and access to virtual care. Telehealth features within engagement platforms enable patients to schedule virtual consultations, receive follow-up care, and communicate with providers through video calls and secure messaging. Remote monitoring tools allow patients to manage conditions from home, tracking symptoms and receiving alerts if their health status changes. By facilitating continuous, remote care, these technologies reduce the need for in-person visits, making healthcare more convenient and accessible. As telehealth adoption grows, it seamlessly integrates with PES, providing a cohesive experience that allows patients to engage in their care without the barriers of time and location.

What Are the Benefits of Patient Engagement Solutions for Patients and Healthcare Providers?

Patient Engagement Solutions provide substantial benefits for patients by improving health outcomes, enhancing accessibility, and fostering a collaborative approach to care, while healthcare providers benefit from increased efficiency, patient satisfaction, and better adherence to care plans. For patients, PES offers a convenient and empowering experience by providing easy access to health information, treatment plans, and communication tools. By enabling patients to view their medical records, schedule appointments, and track their progress, PES supports a sense of control and understanding over their health. Patients with chronic conditions, in particular, benefit from the continuity and consistency offered by PES, as they can receive regular reminders and support for managing their health, leading to improved self-management and adherence to treatment.

For healthcare providers, PES enhances operational efficiency by automating routine tasks such as appointment scheduling, reminders, and follow-ups, reducing administrative burdens and freeing up time for direct patient care. These solutions help providers keep patients engaged and compliant, reducing no-show rates and improving adherence to treatment protocols. By providing patients with clear guidance and access to educational resources, PES reduces the frequency of urgent interventions and hospital readmissions, particularly in chronic disease management. Providers can also track patient progress remotely, receiving updates on patient health metrics and adherence to treatment plans, which allows for timely interventions and better care coordination. For healthcare systems, this proactive approach leads to better patient outcomes and more efficient use of resources.

Improved patient satisfaction and loyalty are other significant benefits of PES, as it enhances the overall care experience by fostering a collaborative and transparent patient-provider relationship. Patients feel more valued and understood when they have continuous access to their health information and the ability to communicate with their providers conveniently. The personalized nature of PES, with features like tailored education, customized care plans, and on-demand communication, makes patients feel actively involved in their care, enhancing trust and engagement. For healthcare providers, satisfied patients are more likely to remain loyal and recommend the practice, supporting long-term patient retention and building a positive reputation. Together, these benefits improve both the clinical and operational aspects of healthcare delivery, supporting a more holistic and patient-centered approach to healthcare.

What Is Fueling the Growth in the Patient Engagement Solutions Market?

The growth in the Patient Engagement Solutions market is driven by rising healthcare consumerism, technological advancements in digital health, increased prevalence of chronic diseases, and regulatory requirements focused on patient-centered care. As healthcare becomes more consumer-driven, patients are seeking convenient, digital tools that offer access to their health information and a personalized approach to care. PES meets this demand by providing user-friendly platforms that empower patients to manage their health on their terms. Patients now expect the same level of service and convenience in healthcare as they experience in other sectors, and PES helps meet these expectations by delivering an accessible, patient-focused experience. As healthcare consumerism rises, the demand for effective and convenient patient engagement solutions is expected to increase.

Technological advancements, particularly in AI, telehealth, and mobile health applications, are also fueling growth in the patient engagement solutions market by enhancing accessibility, personalization, and real-time data sharing. AI-driven tools offer customized guidance, reminders, and health insights that adapt to each patient’s needs, making PES more effective and user-friendly. The widespread adoption of telehealth has further supported the growth of PES by enabling remote consultations and follow-up care, making healthcare more accessible to patients in various locations. Mobile health applications and wearables provide real-time health monitoring, integrating with PES to offer a more interactive and personalized experience. These technologies make PES more versatile, scalable, and appealing, supporting higher adoption rates among healthcare providers and patients alike.

The increasing prevalence of chronic diseases, such as diabetes, cardiovascular disease, and respiratory conditions, has led to a greater need for ongoing patient engagement to support effective disease management. Chronic disease management requires consistent patient monitoring, education, and adherence to treatment plans, all of which are facilitated by PES. With features like remote monitoring, medication reminders, and virtual check-ins, PES plays a crucial role in supporting patients with long-term health conditions, helping them stay engaged and on track with their care plans. As the burden of chronic disease rises globally, healthcare providers are investing in PES to improve patient compliance, reduce hospital readmissions, and ultimately lower the costs associated with chronic care management.

Supportive regulatory requirements and incentives aimed at improving patient engagement and care quality are also driving growth in the PES market. Government healthcare programs and regulatory bodies emphasize patient-centered care and encourage providers to adopt solutions that enhance patient involvement in their own health. Regulations like the U.S. 21st Century Cures Act, which mandates patient access to health records, encourage the adoption of PES to improve transparency and patient empowerment. Additionally, value-based care initiatives incentivize healthcare providers to prioritize patient engagement and health outcomes, further promoting the use of PES. These regulatory factors align with the goals of PES, supporting market growth as providers seek to comply with standards and improve quality of care.

Together, these factors—rising healthcare consumerism, technological advancements, the need for chronic disease management, and supportive regulatory policies—are driving significant growth in the Patient Engagement Solutions market. As healthcare providers strive to offer more accessible, personalized, and efficient care, PES is becoming an integral part of patient-centered healthcare, supporting better outcomes and a more engaged patient population.

SCOPE OF STUDY:

The report analyzes the Patient Engagement Solutions market in terms of US$ Million by the following Application; Component; Therapeutic Area, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware); Therapeutic Area (Chronic Diseases, Women's Health, Fitness, Other Therapeutic Areas); Application (Health Management, Home Health Management, Social & Behavioral Management, Financial Health Management)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 83 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â